|
|
|
Volumn 23, Issue 8, 1996, Pages 1019-1029
|
|
Survival and changes of clinical laboratory data in phase II study with 5'-DFUR
a
a
NONE
|
|
Author keywords
5' DFUR; Cachexia; Survival
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALBUMIN;
ASPARTATE AMINOTRANSFERASE;
DOXIFLURIDINE;
FLUOROURACIL;
GLOBULIN;
LACTATE DEHYDROGENASE;
LENTINAN;
MITOMYCIN C;
TEGAFUR;
UFT;
ANIMAL EXPERIMENT;
ARTICLE;
BREAST CANCER;
CACHEXIA;
CLINICAL LABORATORY;
CLINICAL TRIAL;
COLORECTAL CANCER;
HUMAN;
LIVER FUNCTION;
MAJOR CLINICAL STUDY;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
STOMACH CANCER;
SURVIVAL TIME;
ADMINISTRATION, ORAL;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BLOOD CELL COUNT;
BREAST NEOPLASMS;
CACHEXIA;
COLONIC NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLOXURIDINE;
HUMANS;
MALE;
NEOPLASMS, EXPERIMENTAL;
RECTAL NEOPLASMS;
REMISSION INDUCTION;
STOMACH NEOPLASMS;
SURVIVAL RATE;
|
|
EID: 0029814119
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|